Anxiety does not contribute to social withdrawal in the subchronic phencyclidine rat model of schizophrenia
- 1 October 2017
- journal article
- research article
- Published by Wolters Kluwer Health in Behavioural Pharmacology
- Vol. 28 (7) , 512-520
Abstract
Social withdrawal should not be considered a direct measure of the negative symptoms of schizophrenia as it may result not only from asociality (primary negative symptom) but also from other altered processes such as anxiety. To understand the contribution of these two factors to social deficit, we investigated whether the social withdrawal observed in the subchronic phencyclidine (PCP) rat model of schizophrenia could be attributed to increased anxiety. Compared to saline controls, PCP-treated rats (5 mg/kg, twice daily for 7 days, followed by a washout period) spent significantly less time in social interaction, but did not show anxiety-like behaviors in different relevant behavioral paradigms. In addition, their social deficit was not affected by a behavioral procedure known to reduce anxiety-like behavior (repeated exposure to the same partner) nor by systemic administration of the classical anxiolytic diazepam. In contrast, PCP-induced social withdrawal was reversed by the cannabinoid agonist CP55,940, a drug with known anxiogenic properties. Furthermore, when using the social approach task, PCP-treated animals performed similarly to control animals treated with diazepam, but not to those treated with the anxiogenic compound pentylenetetrazole. Taken together, our results indicate that PCP-induced social withdrawal cannot be attributed to increased anxiety. These data are discussed in the context of primary versus secondary negative symptoms and the deficit syndrome of schizophrenia.Keywords
This publication has 49 references indexed in Scilit:
- Olfactory performance segregates effects of anhedonia and anxiety on social function in patients with schizophreniaJournal of Psychiatry and Neuroscience, 2015
- Impaired Limbic Cortico-Striatal Structure and Sustained Visual Attention in a Rodent Model of SchizophreniaInternational Journal of Neuropsychopharmacology, 2014
- Impact of primary negative symptoms on functional outcomes in schizophreniaEuropean Psychiatry, 2014
- Differential effects of subchronic Phencyclidine on anxiety in the light-enhanced startle-, light/dark exploration- and open field testsBehavioural Brain Research, 2013
- Making choice between competing rewards in uncertain vs. safe social environment: role of neuronal nicotinic receptors of acetylcholineFrontiers in Human Neuroscience, 2013
- Dysfunctional Attitudes and Expectancies in Deficit Syndrome SchizophreniaSchizophrenia Bulletin, 2011
- A review of 25 years of the social interaction testEuropean Journal of Pharmacology, 2003
- Behavioral profile of rats submitted to session 1-session 2 in the elevated plus-maze during diurnal/nocturnal phases and under different illumination conditionsBehavioural Brain Research, 2002
- Resistant outlier rules and the non-Gaussian caseComputational Statistics & Data Analysis, 2000
- Anxiolytic effects of CCK-B antagonistsNeuropeptides, 1991